Greater Manchester Medicines Management Group
Private and voluntary organisations · Health professional committee
First report 22 Apr 2020•Latest report 20 Feb 2026
Reports, concerns and published responses
Reports over time
Reports naming this recipient by issue year.
* 2026 is projected from reports observed to 7 Sep 2026.
- Reports
- 2
- Published responses
- 50%
- Concerns addressed
- 1
- Stated actions
- 7
Naming this recipient
Found for named reports
Across all linked responses
Described in responses
Concerns and recipient responses
Statements from Greater Manchester Medicines Management Group linked to the concerns in each report. Select any concern, action or position to view the source wording.
-
Concerns raised2
Failure of the methotrexate guideline to provide a current therapeutic initial dose
Failure of the methotrexate guideline to define current responsibilities and direct patients to the appropriate healthcare professional
No linked response statementsNo action or position from this recipient is clearly linked to the concerns in this report.
-
Concerns raised1
Failure of psychiatrists to comply with the shared care protocol when requesting GP initiation of Lithium prescriptions
No linked response statementsNo action or position from this recipient is clearly linked to the concerns in this report.
Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations
Data last updated 7 September 2026